1-4 of 4
C.F. LeMaistre
Close
Sort by
Journal Articles

Once Daily Busulfan and Fludarabine Is Well Tolerated and Effective in Older Heavily Treated Patients Prior to Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplant.

Grant W. Potter, Carlos Bachier, MD, Brad Smith, PhD, Maureen Hougham, C.F. LeMaistre, MD, Paul J. Shaughnessy, MD
Journal: Blood
Blood (2007) 110 (11): 4950.
https://doi.org/10.1182/blood.V110.11.4950.4950
Published: 2007
Journal Articles

Once Daily Busulfan Cyclophosphamide Is Well Tolerated and Effective Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

Julia A. LeMaistre, Carlos Bachier, MD, Brad Smith, PhD, C.F. LeMaistre, MD, Paul J. Shaughnessy, MD
Journal: Blood
Blood (2007) 110 (11): 1996.
https://doi.org/10.1182/blood.V110.11.1996.1996
Published: 2007
Journal Articles

Phase I Trial of a Ligand Fusion-Protein (DAB 389 IL-2) in Lymphomas Expressing the Receptor for Interkeukin-2

C.F. LeMaistre, Mansoor N. Saleh, Timothy M. Kuzel, Francine Foss, Leonidas C. Platanias, Gary Schwartz, Mark Ratain, Alain Rook, Cesar O. Freytes, Fiona Craig, James Reuben, Jean C. Nichols
Journal: Blood
Blood (1998) 91 (2): 399–405.
https://doi.org/10.1182/blood.V91.2.399
Published: 1998
Journal Articles

Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients

J.A. Glaspy, E.J. Shpall, C.F. LeMaistre, R.A. Briddell, D.M. Menchaca, S.A. Turner, M. Lill, L. Chap, R. Jones, M.D. Wiers, W.P. Sheridan, I.K. McNiece
Journal: Blood
Blood (1997) 90 (8): 2939–2951.
https://doi.org/10.1182/blood.V90.8.2939
Published: 1997